On 24 February, in Brussels and online, EURORDIS will bring the rare disease community together for its fifteenth Black Pearl Awards ceremony, held in the lead‑up to Rare Disease Day.

EURORDIS Black Pearl Awards 2026: celebrating rare disease champions in Brussels and online

Black Pearl Awards

The EURORDIS Black Pearl Awards have been held annually since 2012 to recognise outstanding achievements by people living with a rare disease and those working alongside them — including patient advocates and organisations, policymakers, scientists, companies and others committed to improving lives. Since February 2023, the awards have been a fully hybrid event, with both in‑person participation in Brussels and an online platform.

For 2026, the ceremony will take place on Tuesday, 24 February at the Cardo Hotel, Brussels, with online participation available via EURORDIS’ interactive platform. The awards ceremony will also be translated into 61 languages.

2026 awardees highlighted

Among the 2026 awardees are: Jakub Dvořáček, recipient of the EURORDIS Policy Maker Award; Saventic Health, recipient of the EURORDIS Company Award for Health Technology; Dr Ágnes Cser, recipient of the EURORDIS Leadership Award; and Roche and King’s College London, as project leads of the AIMS-2-TRIALS consortium, recipients of the EURORDIS Company Award for Patient Engagement.

More information and registration details and agenda are available here.

News & Updates

You might also be interested in

Bringing clinicians, researchers, patient representatives and families together, the event examined how shorter diagnostic pathways depend not only on better tests, but on shared expertise, structured phenotyping and patient-centred support.
ERDERA and the European Genomic Data Infrastructure have signed a Memorandum of Understanding to strengthen collaboration on secure cross-border access to genomic, clinical and other health-related data, supporting rare disease research and the development of personalised medicine in Europe.
Young advocates met in Paris from 23–25 April 2026 for the second ERDERA Training for Young Advocates for Rare Diseases, focused on advocacy, clinical research, patient rights and partnership in paediatric rare disease research.
Preliminary results point interest across the rare disease research community, while highlighting underrepresentation of some countries and stakeholders